By OM1 | February 2025 Hidradenitis Suppurativa (HS) is a chronic and debilitating skin condition that presents significant challenges for patients and healthcare providers alike. Many patients suffer for years without an accurate diagnosis, causing painful nodules on the skin to worsen over time. HS is often associated with systemic mental health, immunologic, and cardiometabolic[…]

By Richard Gliklich, MD, CEO, OM1 In the rapidly evolving landscape of clinical trials, data collection remains one of the most time-consuming and cost-intensive processes. For decades, the manual abstraction of clinical data into electronic case report forms (eCRFs) has been the predominant method for gathering information from trial participants. This paradigm, largely unchanged since[…]

Rheumatologic diseases like systemic lupus erythematosus (SLE), ankylosing spondylitis, and rheumatoid arthritis can present significant challenges for biopharma. These conditions are chronic, complex, and multisystemic. While traditional clinical trials provide essential insights, they often fail to capture the full spectrum of patient experiences or reflect the diversity seen in real-world populations. Real-world data (RWD), combined[…]

By Vadim Pinsky, PhD, and Gabe Goldfeder, M.A. One of the key frameworks for understanding data analytics in Real-World Evidence (RWE) is the “Five Vs”: Velocity, Volume, Variety, Veracity, and Value. Each aspect plays a crucial role in the data collection and analysis process, shaping how efficiently and accurately insights are generated. For healthcare professionals,[…]

Understanding the patient journey has become crucial for improving treatment outcomes and addressing unmet needs. Pharmaceutical companies need deeper insights into the patient experience — from initial symptoms through diagnosis, treatment, and long-term management – to improve market visibility and marketing opportunities, demonstrate the value of treatments and treatment effectiveness, and ensure the right patients[…]